Search results
Results from the WOW.Com Content Network
Many healthcare investors look at Johnson & Johnson (NYSE: JNJ) and see a good, safe dividend stock. But I see an investment that's full of uncertainty and risk. The company continually runs into ...
Johnson & Johnson On April 1, 2020, Johnson & Johnson stock was trading for $150 per share. In mid-July 2021, it’s up to $169, which is close to its 52-week high of $173.65.
The offer also represents a 17% premium to the stock's closing price in late March, when the Wall Street Journal reported J&J's interest in Shockwave, whose shares were currently trading at $326.82.
Johnson & Johnson. / 40.49861°N 74.44361°W / 40.49861; -74.44361. Johnson & Johnson ( J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones ...
Johnson and Johnson (NYSE:JNJ) stock was recently upgraded to Outperform by a Bernstein analyst as "historically cheap." JNJ stock is off its 52-week highs almost 12%. It seems the market has ...
Jennifer Taubert. Number of employees. 45.000. Parent. Johnson & Johnson. Website. www.janssen.com. Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen .
J&J acquired the rest of the company in October 2010, taking its stake to over 95% by February 2011 and delisting the company from stock exchanges two months later. After the takeover by Johnson & Johnson in 2011, Crucell was assigned to Janssen Pharmaceuticals division. In 2014, the subsidiary was renamed from Crucell to Janssen Vaccines.
After posting good earnings, Johnson & Johnson's ( NYSE:JNJ )stock rallied over 5% to make a new all-time high. Today we will take a look at the company's return on equity (ROE) to assess how ...